Here's some of the buzz pushing this stock right now. It is only a blog, but the data is available and will be presented at the end of the month. The company is hosting an annual shareholders meeting webcast tomorrow at 5 PM EST. Lots of buzz making its way around this one. I don't pretend to understand the nuances of biotechs, but the data dumbed down for me looks impressive. People are now looking for the next Dendreon, and AGEN has a similar type of cancer vaccine approach for brain cancer (glioma) that made Dendreon a 5 billion market cap company before approval of their first drug.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.